Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative

Key Points MLOF used an innovative approach to genotype 3000 hemophilia patients identifying likely causative variants in 98.4% of patients. Hemophilia genotyping should include structural variation, F8 inversions (for hemophilia A), and consideration of gene-wide approaches.